Amphastar Pharmaceuticals, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US03209R1032
USD
19.57
0.34 (1.77%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
719.89
731.97
644.39
498.99
437.77
349.85
322.36
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
719.89
731.97
644.39
498.99
437.77
349.85
322.36
Raw Material Cost
378.43
370.60
300.43
260.19
249.27
216.55
199.17
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
25.48
30.34
27.16
1.85
0.89
0.37
0.12
Selling and Distribution Expenses
129.81
94.52
80.39
66.59
68.56
65.02
62.97
Other Expenses
4.58
3.11
3.67
6.29
4.88
5.67
6.01
Total Expenditure (Excl Depreciation)
579.48
526.55
444.71
391.49
367.53
338.65
322.40
Operating Profit (PBDIT) excl Other Income
140.39999999999998
205.39999999999998
199.7
107.5
70.19999999999999
11.200000000000001
0
Other Income
4.40
9.69
-4.37
5.46
-1.17
6.86
0.49
Operating Profit (PBDIT)
208.01
272.31
237.09
141.70
95.82
43.24
21.57
Interest
25.48
30.34
27.16
1.85
0.89
0.37
0.12
Exceptional Items
4.30
5.00
3.20
4.93
15.96
-13.04
59.90
Gross Profit (PBDT)
341.45
361.37
343.97
238.80
188.50
133.29
123.19
Depreciation
63.20
57.20
41.78
28.74
26.75
25.18
21.12
Profit Before Tax
123.62
189.76
171.36
116.04
84.14
4.64
60.23
Tax
25.53
29.67
31.83
23.48
20.63
3.54
13.72
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
98.09
159.52
137.54
91.39
62.12
1.40
48.94
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
98.09
159.52
137.54
91.39
62.12
1.40
48.94
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
1.19
-0.31
-2.43
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
98.09
159.52
137.54
91.39
63.30
1.10
46.51
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
788.80
732.30
639.42
528.66
445.52
402.31
381.37
Earnings per share (EPS)
2.03
3.06
2.6
1.74
1.25
0.03
0.98
Diluted Earnings per share
2.03
3.06
2.6
1.74
1.25
0.03
0.98
Operating Profit Margin (Excl OI)
19.5%
28.06%
30.99%
21.54%
16.04%
3.2%
-0.01%
Gross Profit Margin
25.95%
33.74%
33.08%
29.01%
25.33%
8.52%
25.24%
PAT Margin
13.63%
21.79%
21.34%
18.31%
14.19%
0.4%
15.18%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is -1.65% vs 13.59% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is -38.50% vs 16.00% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is -22.47% vs 8.74% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -15.84% vs 11.40% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has fallen from Dec 2024

Compare Annual Results Of Amphastar Pharmaceuticals, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
719.89
673.00
46.89
6.97%
Other Operating Income
0.00
0.00
0.00
Total Operating income
719.89
673.00
46.89
6.97%
Raw Material Cost
378.43
136.00
242.43
178.26%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
25.48
62.00
-36.52
-58.90%
Selling and Distribution Expenses
129.81
349.00
-219.19
-62.81%
Other Expenses
4.58
66.10
-61.52
-93.07%
Total Expenditure (Excl Depreciation)
579.48
1,208.00
-628.52
-52.03%
Operating Profit (PBDIT) excl Other Income
140.40
-535.00
675.40
126.24%
Other Income
4.40
26.00
-21.60
-83.08%
Operating Profit (PBDIT)
208.01
-474.00
682.01
143.88%
Interest
25.48
62.00
-36.52
-58.90%
Exceptional Items
4.30
0.00
4.30
Gross Profit (PBDT)
341.45
537.00
-195.55
-36.42%
Depreciation
63.20
35.00
28.20
80.57%
Profit Before Tax
123.62
-571.00
694.62
121.65%
Tax
25.53
4.00
21.53
538.25%
Provisions and contingencies
0
0
0.00
Profit After Tax
98.09
-575.00
673.09
117.06%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
98.09
-575.00
673.09
117.06%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
98.09
-575.00
673.09
117.06%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
788.80
-80.00
868.80
1,086.00%
Earnings per share (EPS)
2.03
-5.83
7.86
134.82%
Diluted Earnings per share
2.03
-5.83
7.86
134.82%
Operating Profit Margin (Excl OI)
19.50%
-79.49%
0.00
98.99%
Gross Profit Margin
25.95%
-79.64%
0.00
105.59%
PAT Margin
13.63%
-85.44%
0.00
99.07%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 71.99 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -1.65% vs 13.59% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 9.81 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -38.50% vs 16.00% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.36 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -22.47% vs 8.74% in Dec 2024

Annual - Interest
Interest 2.55 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -15.84% vs 11.40% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.50%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has fallen from Dec 2024